Institutional Repository (UniKL IR)
Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/26283| Title: | A narrative review on the effectiveness of tocilizumab in reducing the mortality risk in covid-19 patients |
| Authors: | Nur Haifa Amani Zulkiply Vignesh, Ramachandran Muthukumarasamy, Ravindran (UniKL RCMP) |
| Keywords: | COVID-19 Cytokine storm Interleukin-6 inhibitors SARS-CoV-2 Tocilizumab |
| Issue Date: | Jul-2021 |
| Publisher: | Universiti Putra Malaysia Press |
| Citation: | Nur Haifa Amani Zulkiply, Vignesh, R., & Muthukumarasamy, R. (2021). A Narrative Review on the Effectiveness of Tocilizumab in Reducing the Mortality Risk in COVID-19 Patients. Malaysian Journal of Medicine and Health Sciences, 17(3), 2636–9346. https://medic.upm.edu.my/upload/dokumen/2021062816053138_MJMHS_0854.pdf |
| Abstract: | The novel coronavirus disease 2019 (COVID-19) has reached its pandemic scale within a short period of its first case reported in Wuhan, China in December 2019, leading to a great economic crisis all over the world. As of today, there is no clinically approved antiviral drug available for the treatment of COVID-19. Tocilizumab, a humanized monoclonal antibody against the interleukin-6 (IL-6) receptor, clinically approved for the treatment of rheumatoid arthritis, is one such drug used to manage the COVID-19 symptoms. The current study reviews the effectiveness of Tocilizumab as a treatment option for COVID-19. Research findings on Tocilizumab are effective in COVID-19 patients with the risk of cytokine storm and further complications. Nevertheless, this review also recommends further investigation on the effectiveness of this drug with a large group of patients for more accuracy in results with COVID 19 patients |
| URI: | https://medic.upm.edu.my/jurnal_kami/penerbitan/mjmhs_vol_17_no_3_july_2021-62220 http://hdl.handle.net/123456789/26283 |
| ISSN: | 16758544 |
| Appears in Collections: | Journal Articles |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| A narrative review on the effectiveness of tocilizumab in reducing the mortality risk in covid-19 patients .pdf | 353.38 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.